United States Drug Enforcement Administration

WASHINGTON – The U.S. Drug Enforcement Administration is announcing three new rules to make permanent some temporary telemedicine flexibilities established during the COVID-19 public health emergency while also establishing new patient protections. In developing these rules, DEA has focused on the patient to ensure telemedicine is accessible for medical care...